Combined oestrogen-progestogen replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women

British Journal of Clinical Pharmacology

Volumn 47, Issue 3, 1999, Pages 315-321

  Yichuan, Wen ^a,d   Doyle, Miriam C T ^b   Norris, Lucy A ^a   Sinnott, Margaret M ^a   Cooke, Thomas ^c   Harrison, Robert F ^b   Feely, John ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b ROTUNDA HOSPITAL   (Ireland)

^c DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^d UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

Antioxidant; Atherosclerosis; Hormone replacement therapy (HRT); LDL oxidation; Oestrogen; Postmenopause; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ESTROGEN; GESTAGEN; LOW DENSITY LIPOPROTEIN; MEDROXYPROGESTERONE ACETATE; PIPERAZINE ESTRONE SULFATE;

ADULT; ARTICLE; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPOPROTEIN METABOLISM; NORMAL HUMAN; OXIDATION; POSTMENOPAUSE; PRIORITY JOURNAL;

CHOLESTEROL; DRUG THERAPY, COMBINATION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; LIPOPROTEIN(A); LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MIDDLE AGED; OXIDATION-REDUCTION; POSTMENOPAUSE; PROGESTINS; TREATMENT OUTCOME; VITAMIN E;

EID: 0032994703     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00895.x     Document Type: Article

References (41)

1. 1 Manson JE. Postmenopausal hormone therapy and atherosclerotic disease. Am Heart J 1994; 128: 1337-1343.
2. 2 Seed M, Crook D. Postmenopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins. Curr Opinin Lipidol 1994; 5: 48-58.
3. 3 Whitehead M, Lobo RA. Progestogen use in postmenopausal women. Lancet 1988; ii: 1243-1244.
4. 4 Punnonen RH, Jokela HA, Dastidar PS, Nevala M, Laippala PJ. Combined oestrogen-progestin replacement therapy prevents atherosclerosis in postmenopausal women. Maturitas 1995; 21: 179-187.
5. 5 Rosano GM, Sarrel PM. Ovarian hormones and the cardiovascular system: recent findings. Cardiologia 1994; 39: 275-279.
6. 6 Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-798.
7. 7 Jialal I, Grundy SM. Effect of combined supplementation with α-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation. Circulation 1993; 88: 2780-2786.
8. 8 Bjorkhem I, Henriksson-Freyschuss A, Breuer O. The antioxidant bulylated hydroxytoluene protects against atherosclerosis. Arteriosclerosis 1991; 11: 15-22.
9. 9 Hodis HN, Mack WJ, LaDree L, et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 1995; 273: 1849-1854.
10. 10 Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick KM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996; 334: 1156-1162.
11. 11 Rapola JM, Virtamo J, Haukka J, et al. Effect of vitamin E and beta carotene on the incidence of angina pectoris. JAMA 1996; 275: 693-698.
12. 12 Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr 1996; 64: 190-196.
13. 13 Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-786.
14. 14 Huber LA, Scheffler E, Poll T, Ziegler R, Dresel HA. 17 beta-estradiol inhibits LDL oxidation and cholesteryl macrophages. Free Rad Res Comm 1989; 8: 167-173.
15. 15 Sack MN, Rader DJ, Cannon III RO. Oestrogen and inhibition of oxidation of low-density lipoprotein in postmenopausal women. Lancet 1994; 343: 269-270.
16. 16 Maziere C, Auclair M, Ronveaux MF, Salmon S, Santus R, Maziere JC. Estrogen inhibit copper and cell-mediated modification of low-density lipoprotein. Atherosclerosis 1991; 89: 175-182.
17. 17 Salonen JT, Yla-Hertuala S, Yamamoto R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992; 339: 883-887.
18. 18 Regnstrom J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992; 339: 1183-1186.
19. 19 Mukai K, Daifuku K, Yokoyama S, Nakano M. Stopped-flow investigation of antioxidant activity of estrogens in solution. Biochim Biophys Acta 1990; 1035: 348-352.
20. 20 Chung BH, Segrest JP, Ray MJ. Single vertical spin gradient ultracentrifugation. Methods Enzymol 1986; 128: 181-209.
21. 21 Markwell MAK, Haas S, Tolbert NE, Bieber LL. Protein determination in membrane and lipoprotein samples: manual and automated procedures. Methods Enzymol 1981; 72: 296-300.
22. 22 Palinski W, Rosenfeld ME, Yla-Herttuala S. et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci 1989; 86: 1372-1376.
23. 23 Maggi E, Bellazzi R, Gazo A, Seccia M, Bellomo G. Autoantibody against oxidatively-modified LDL in uremic patients undergoing dialysis. Kidney Int 1994; 46: 869-876.
24. 24 Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-310.
25. 25 Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comm 1988; 6: 67-75.
26. 26 Dieber-Rotheneder M, Puhl W, Waeg G, Striegl G, Esterbauer H. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low-density lipoproteins and resistance to oxidation. J Lipid Res 1991; 32: 1325-1332.
27. 27 Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA. Separation and quantitation of subclasses of human plasma high density lipoprotein by a simple precipitation peocedure. J Lipid Res 1982; 23: 1206-1223.
28. 28 Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of the LDL cholesterol in plasma, without use of the centrifuge. Clin Chem 1972; 18: 499-502.
29. 29 O'Leary VJ, Tilling L, Fleetwood G, Stone D, Darley-Usmar V. The resistance of low density lipoprotein to oxidation promoted by copper and its use as an index of antioxidant therapy. Atherosclerosis 1996; 119: 169-179.
30. 30 Dunn JF, Nisula BC, Rodbard D. Transport of steriod hormones: binding of 21 endogenous steriods to both testosterone-binding and corticosterone-binding globulin in human plasma. J Clin Endocrinol Metab 1981; 53: 58-68.
31. 31 Siiteri PK, Murai JT, Hammond GL, Nisker JA, Raymoure WJ, Kuhn RW. The serum transport of steriod hormones. Recent Prog Horm Res 1982; 38: 457-510.
32. 32 Niki E, Noguchi N, Gotoh N. Inhibition of oxidative modification of low density lipoprotein by antioxidants. J Nutr Sci Vitaminol 1993; 39: S1-S8.
33. 33 Ciavatti M, Renaud S. Oxidative status and oral contraceptive: its relevance to platelet abnormalities and cardiovascular risk. Free Rad Biol Med 1991; 10: 325-338.
34. 34 Roy D, Kalyanaraman B, Leihr JG. Xanthine oxidase-catalyzed reduction of estrogen quinones to semiquinones and hydroquinones. Biochem Pharmacol 1991; 42: 1627-1631.
35. 35 Campos H, Sacks FM, Walsh BW, Schiff I, O'Hanesian MA, Krauss RM. Differential effects of oestrogen on low-density lipoprotein subclasses in healthy postmenopausal women. Metabolism 1993; 42: 1153-1158.
36. 36 van der Mooren MJ, de Graaf J, Demacker PNM, de Haan AFJ, Rolland R. Changes in the low-density lipoprotein profile during 17 β-estradiol-dydrogesterone therapy in postmenopausal women. Metabolism 1994; 43: 799-802.
37. 37 Austin MA, Edwards KL. Small, dense low density lipoprotein, the insulin resistance syndrome and noninsulin-dependent diabetes. Curr Opin Lipidol 1996; 7: 167-171.
38. 38 Tribble DL, Thiel PM, van den Berg JJM, Krauss RM. Differing α-tocopherol oxidative lability and ascorbic acid sparing effects in buoyant and dense LDL. Arterioscler Thromb Vasc Biol 1995; 15: 2025-2031.
39. 39 Reaven PD, Herold DA, Barnett J, Edelman S. Effects of vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM. Diabetes Care 1995; 18: 807-816.
40. 40 Nenseter MS, Volden V, Berg T, Drevon CA, Ose L, Tonstad S. Effect of hormone replacement therapy on the susceptibility of low-density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women. Eur J Clin Invest 1996; 26: 1062-1068.
41. 41 Rifici VA, Khachadurian AK. The inhibition of low-density lipoprotein oxidation by 17-β estradiol. Metabolism 1992; 41: 1110-1114.